跳至主要内容
临床试验/ACTRN12619001247167
ACTRN12619001247167招募中未知

Prospective Clinical Drug-Drug Interaction study between Rifampicin and Fusidic Acid in the context of staphylococcal infection

St Vincent's Hospital Melbourne0 个研究点目标入组 12 人开始时间: 2019年9月10日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
12

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Inpatients with presumed or confirmed staphylococcal infection
  • -A decision to treat with oral rifampicin and fusidic acid has already been made but not started.
  • -Treatment with an intravenous beta-lactam antibiotic

排除标准

  • -Previous adverse reaction to rifampicin or fusidic acid
  • -Pregnancy
  • -The taking of other essential medications with a known significant interaction with rifampicin and fusidic acid
  • -Liver failure
  • -Unlikely to receive antibiotic treatment for longer than 4 weeks
  • -Primary intravenous treatment with vancomycin or teicoplanin
  • -Already on treatment with intravenous rifampicin

研究者

发起方
St Vincent's Hospital Melbourne

相似试验